- Home
- News
- Treatment & Care
- HIV Worldwide
- Living with HIV
- Preventing HIV
- Organisations
- HIV Basics
- About Us
information for people living and working with HIV
HIV Worldwide
-
Adherence
-
Children
-
Clinical reviews
-
Drug supply
-
Guidelines
-
Hepatitis and HIV coinfection
-
HIV Testing
-
Infant feeding
-
Laboratory monitoring
-
Malaria & HIV
-
Mental health and HIV
-
Neurological problems, including HIV dementia
-
Nutrition
-
Palliative care
-
Prevention
-
Prevention of mother-to child transmission
-
Scaling up treatment and models of service delivery
-
Side-effects
-
South Africa
-
Starting treatment
- Switching from efavirenz to nevirapine in women with higher CD4 counts - 07/05/09
- Universal testing and immediate treatment could cut HIV infections by 95% in 10 years - 27/11/2008
- First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
- How to deliver good adherence support: lessons from round the world - 10/9/2007
- WHO to monitor ARV side-effects worldwide - 11/9/2007
- First-line treatment choices proving challenging for African ART programmes - 11/9/2007
- A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
- Patient retention challenges and the need for more active follow-up - 22/3/2007
- Lowering the threshold - Is there a case for re-evaluating eligibility criteria for ART? - 1/11/2006
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
- Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
- Immune reconstitution inflammatory syndrome (IRIS) in the developing world - 27/10/2005
- Symptoms versus laboratory monitoring as criteria for starting treatment - 27/10/2005
- Fixed-dose ARV combinations: choices and challenges - 27/10/2005
- Monitoring ARV treatment - 27/10/2005
- Combining ARVs with treatment for tuberculosis - 27/10/2005
- Nevirapine-based fixed-dose combination ARVs - 27/10/2005
- Co-trimoxazole prophylaxis - 27/10/2005
-
Stigma
-
Task shifting
-
Treatment failure
-
Tuberculosis
-
Viral load testing
feedback
Give us your views on our work
Starting treatment
-
Switching from efavirenz to nevirapine in women with higher CD4 counts - 07/05/09
-
Universal testing and immediate treatment could cut HIV infections by 95% in 10 years - 27/11/2008
-
First-line antiretroviral therapy: not as simple as we'd like it to be - 19/06/08
-
How to deliver good adherence support: lessons from round the world - 10/9/2007
-
WHO to monitor ARV side-effects worldwide - 11/9/2007
-
First-line treatment choices proving challenging for African ART programmes - 11/9/2007
-
A follow-up on follow-up: shifting to a community-based response to improve retention in care - 31/8/2007
-
Patient retention challenges and the need for more active follow-up - 22/3/2007
-
Lowering the threshold - Is there a case for re-evaluating eligibility criteria for ART? - 1/11/2006
-
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part One - 27/10/2005
-
Treatment equity in practice: how scarce resources for treatment are being used, and the ethical dilemmas that need to be debated - Part Two - 27/10/2005
-
Immune reconstitution inflammatory syndrome (IRIS) in the developing world - 27/10/2005
-
Symptoms versus laboratory monitoring as criteria for starting treatment - 27/10/2005
-
Fixed-dose ARV combinations: choices and challenges - 27/10/2005
-
Monitoring ARV treatment - 27/10/2005
-
Combining ARVs with treatment for tuberculosis - 27/10/2005
-
Nevirapine-based fixed-dose combination ARVs - 27/10/2005
-
Co-trimoxazole prophylaxis - 27/10/2005
About HATIP
A regular electronic newsletter for health care workers and community-based organisations on HIV treatment in resource-limited settings.
Its publication is supported by the UK government's Department for International Development (DfID), the Diana, Princess of Wales Memorial Fund and the Stop TB Department of the World Health Organization.
latest aidsmap news
- Drug-resistant TB now at record levels, says WHO
- Weight gain after starting ART predicts survival
- Aciclovir shows lower efficacy outside US in global trial
- `Test and treat` prevention approach may not require universal treatment to succeed
- Over a third of TB cases in UK prisons are drug-resistant
- High prevalence of drug-resistant TB amongst HIV patients in South Africa
- Genital ulcers frequently associated with HIV shedding in men
- HIV biggest cause of adolescent death, hospitalisation in Zimbabwe
- Visa refusal shines spotlight on China's HIV travel ban
- Rates of new HIV diagnoses amongst US gay men 44 times greater than those in other populations